CAS: 251356-45-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | SU 16f REF: IN-DA00C4IJCAS: 251356-45-3 | 98% | To inquire | Mon 02 Dec 24 |
 | PDGFR Tyrosine Kinase Inhibitor VII REF: 3D-BKA35645CAS: 251356-45-3 | Min. 95% | To inquire | Mon 13 Jan 25 |
 | SU16f REF: TM-T16947CAS: 251356-45-3 | 98.38% | 46.00 €~427.00 € | Tue 21 Jan 25 |
Ref: IN-DA00C4IJ
| 5mg | 299.00 € | ||
| 10mg | 503.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
PDGFR Tyrosine Kinase Inhibitor VII
CAS:251356-45-3
PDGFR Tyrosine Kinase Inhibitor VII is a protein-based drug that binds to the PDGFR tyrosine …
Formula:
C24H22N2O3
Purity:
Min. 95%
Molecular weight:
386.44 g/mol
Ref: 3D-BKA35645
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
SU16f
CAS:251356-45-3
SU16f, a 3-substituted indolin-2-one, is a selective PDGFRβ inhibitor; IC50: 10 nM (PDGFRβ), 140 nM …
Formula:
C24H22N2O3
Purity:
98.38%
Color and Shape:
Solid
Molecular weight:
386.44
Ref: TM-T16947
| 1mg | 46.00 € | ||
| 5mg | 95.00 € | ||
| 10mg | 124.00 € | ||
| 25mg | 199.00 € | ||
| 50mg | 296.00 € | ||
| 100mg | 427.00 € | ||
| 1mL*10mM (DMSO) | 97.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
